A. Bernard et al., THE VALUE OF SURGERY IN THE TREATMENT OF INVASIVE PULMONARY ASPERGILLOSIS IN NEUTROPENIC PATIENTS, Revue des maladies respiratoires, 15(1), 1998, pp. 49-55
The aim of the study is to specify the indication for surgery in the t
reatment of invasive pulmonary aspergillosis (APII. From January 1991
to October 1996 nineteen patients who had been treated with chemothera
py and associated marrow aplasia and suffering from API were operated
on. At the lime of the surgical intervention all of the patients were
treated with antifungal drugs. The delay between the start of their sy
mptoms and the start of treatment was 2.6 days (range: 0-17 days). 1.
The risk of a massive haemoptysis by contact between the fungal infect
ion and the pulmonary artery led to eight urgent surgical operations:
six lobectomies and two lobectomies associated with segmentectomy. The
mean level of polymorphonuclear neutrophils was 296 cell/mm(3) (0-1,0
00). Plastic surgery on the pulmonary artery was carried out in three
patients. One patient died after the operation with progression of the
API. The duration of postoperative stay was 13 days (6-18). 2. Planne
d surgery consisted of a resection of the residual mass after antifung
al treatment and a diagnostic approach to the intraparenchymatous mass
of indeterminate aetiology. A resection of the residual masses (in sp
ite of antifungal treatment) was carried out in seven patients: before
further haematological therapy in six cases and iii one case for a su
perinfected lesion. The type of resection was. a lobectomy (n = 4), a
lingulectomy (n = 1) and an atypical resection (n = 2). No postoperati
ve deaths were reported. The patients left the surgical service betwee
n the seventh and twentieth clay postoperatively. The surgery was used
in Sour patients as the diagnostic approach in view of intraparenchym
al masses of unknown aetiology and had enabled a fungal mycelium to be
isolated at the centre of persisting inflammation. Antifungal treatme
nt sometimes associated with surgery allowed for a better prognosis in
patients suffering from invasive pulmonary aspergillosis.